Company Overview
Snapshot
Founded in July 2022 by Gal Admati, Shimon Lecht, and Liat Avrahami Moyal, Fungit Biosolutions operates with 1–10 employees. The company has secured $1.5 million across two funding rounds, with InNegev as an investor. In November 2023, Fungit Biosolutions appointed Gal Admati as its new CEO, signaling a strategic leadership transition for the agritech firm.
Business overview
Fungit Biosolutions is dedicated to enhancing global food security by extending the shelf life of fruits and vegetables and improving crop yields. The company leverages fungal-based microorganisms as sustainable biocontrol agents to protect crops from extreme weather conditions and fungal diseases. Utilizing microbiological genome sequencing and bioinformatic approaches, Fungit develops proprietary, tailor-made biocontrol solutions for the agriculture and food industries, specifically targeting crops like row crops and vines.
Strategic signal
In November 2023, Fungit Biosolutions appointed Gal Admati as CEO. This leadership change is a significant development, as Admati previously served as Head of Venture Creation and Business Development at InNegev, an incubator under which Fungit operates. This appointment signals a strategic move to leverage deep incubator-level insight and experience to accelerate product development and market entry, particularly as the company aims to bring its bio-fungicide product to market by the end of 2026.
Log in to access full profile ›Company Intelligence Q&A
- What is Fungit Biosolutions' primary mission?
- Fungit Biosolutions' mission is to improve global food security by extending fruit and vegetable shelf life and enhancing crop yield through the use of fungal-based microorganisms as sustainable biocontrol agents.
- When was Fungit Biosolutions founded and by whom?
- Fungit Biosolutions was founded in July 2022 by Gal Admati, Shimon Lecht, and Liat Avrahami Moyal.
- What was a key leadership change at Fungit Biosolutions in late 2023?
- In November 2023, Fungit Biosolutions appointed Gal Admati as its new CEO. Admati previously held roles at NLT-SPINE, Eye-Yon Medical, Nanopass Technologies, and as Head of Venture Creation and Business Development at InNegev.
- What is Fungit Biosolutions' total disclosed funding?
- Fungit Biosolutions has raised a total of $1.5 million across two funding rounds, with InNegev as an investor.
- What is Fungit Biosolutions' approach to addressing food waste and climate impact?
- Fungit Biosolutions develops host-driven biological solutions to improve crop yield under various conditions and reduce post-harvest crop waste caused by fungal pathogens. This approach aims to increase food production efficiency, reduce resource consumption, and mitigate the environmental impact associated with food loss.